Pay attention to the study on active antiliver fibrosis components of Chinese herbal medicine (original) (raw)

Abstrac

In this review, the researches on Chinese herb components with anti-hepatic fibrosis activity in China in the recent 20 years were generalized. Almost thirty active herb components attracted author’s attention, especially, salvianolic acid B and oxymatrine which were investigated comprehensively. Moreover, the author considered that, in view of the complex pathogenesis and the multi-pathway and multi-target superiority of Chinese medicine formula, the effective components formula investigations deserve more attention and probably prompt a potential researching direction.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Li XM, Li HS, Hu YY. Research progress of anti-liver fibrosis herbal ingredients or constituents. Chin J Integr Tradit West Med Liver Dis (Chin) 2008;18:186–189.
    CAS Google Scholar
  2. Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002;8:679–685.
    PubMed CAS Google Scholar
  3. Hu YY, Liu P, Liu C, Gu HT, Xu LM, Liu CH, et al. Influence of the extract of Radix Salviae Miltiorrhizae on hepatic fibrosis induced by CCl4 and DMN in rats. Shanghai J Tradit Chin Med (Chin) 1999;33:7–10.
    Google Scholar
  4. Liu CH, Liu P, Hu YY, Zhu DY. Effects of salvianolic acid-B on TGF-β1 stimulated hepatic stellate cell activation and its intracellular signaling. Natl Med J China (Chin) 2002;82:1267–1272.
    CAS Google Scholar
  5. Tao YY, Wang XL, Liu CH. Salvianolic acid-B effects on TGF-β1/ERK signaling transduction in NIH/3T3 fibroblast. J Capit Med Univ (Chin) 2007;28:192–195.
    CAS Google Scholar
  6. Mao YM, Zeng MD, Lu LG, Li JQ, Wan MB, Li CZ, et al. Oxymatrine capsule in the treatment of liver fibrosis in patients with chronic virus hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study (II). Chin Hepatol (Chin) 2002;4:222–225.
    Google Scholar
  7. Zen WZ, Wu XL, Jiang MD. Effect of oxymarine on Smad gene expression in CCl4-induced hepatic fibrosis in rats. World J Dig (Chin) 2005;13:984–987.
    Google Scholar
  8. Song J, Wang LL, Zhu L, Zhong HM, Yao P. Effects of oxymatrine on procollagen III metabolism and its gene expression in experimental fibrotic rats. Chin J Hepatol (Chin) 2003;11:697.
    Google Scholar
  9. Lu Q, Zhang QB, Zhang JM, Yin YK, Wu XH. The inhibition effect of oxymatrine on the activation of paracrine pathway of hepatic stellate cells. Chin Hepatol (Chin) 2004;9:31–33.
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Liver Diseases, Shanghai University of Chinese medicine, Shanghai, 201203, China
    Yi-yang Hu (胡义扬)

Rights and permissions

About this article

Cite this article

Hu, Yy. Pay attention to the study on active antiliver fibrosis components of Chinese herbal medicine.Chin. J. Integr. Med. 18, 563–564 (2012). https://doi.org/10.1007/s11655-012-1029-7

Download citation

Keywords